Tevogen Inc. (TVGNW)
Sector: Biological Products, (No Diagnostic Substances)
Tevogen Inc.
NASDAQ:TVGNWSub-class of TVGN
-2.64%$0.0847
CLOSED · Nov 6Prev close$0.0870-2.64%Close$0.0847+3.90%AH close$0.0880
AH$0.0880+3.90%vs close
Mkt Cap$5.75M
Float43.58M
O/S67.88M
VOL759K sh
$ Vol$62K
RVOL1.50×
Inst Own-
SI0.2%
EarningsNov 13 · in 4d
Dilution
MCap$5.75M
Float43.58M
O/S67.88M
Dilution
Historical Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 6, 2026 | 0.0850 | 0.0897 | 0.0755 | 0.0847 | 758,662 |
| Nov 5, 2026 | 0.0860 | 0.0895 | 0.0758 | 0.0870 | 182,782 |
| Nov 4, 2026 | 0.0875 | 0.0999 | 0.0822 | 0.0868 | 307,342 |
| Nov 3, 2026 | 0.0938 | 0.1000 | 0.0767 | 0.0767 | 420,618 |
| Nov 2, 2026 | 0.0890 | 0.0999 | 0.0760 | 0.0783 | 422,785 |
| Oct 30, 2026 | 0.0908 | 0.0975 | 0.0751 | 0.0875 | 627,927 |
| Oct 29, 2026 | 0.0900 | 0.0975 | 0.0717 | 0.0740 | 808,244 |
| Oct 28, 2026 | 0.0825 | 0.1175 | 0.0706 | 0.0845 | 894,971 |
| Oct 27, 2026 | 0.0730 | 0.0900 | 0.0650 | 0.0804 | 934,521 |
| Oct 26, 2026 | 0.0689 | 0.0774 | 0.0640 | 0.0728 | 660,806 |
| Oct 23, 2026 | 0.0636 | 0.0689 | 0.0606 | 0.0672 | 562,972 |
| Oct 22, 2026 | 0.0630 | 0.0689 | 0.0608 | 0.0650 | 680,940 |
| Oct 21, 2026 | 0.0615 | 0.0687 | 0.0602 | 0.0648 | 836,127 |
| Oct 20, 2026 | 0.0602 | 0.0678 | 0.0550 | 0.0630 | 534,886 |
| Oct 19, 2026 | 0.0655 | 0.0683 | 0.0421 | 0.0636 | 752,007 |
| Oct 16, 2026 | 0.0683 | 0.0689 | 0.0599 | 0.0689 | 113,481 |
| Oct 15, 2026 | 0.0700 | 0.0700 | 0.0685 | 0.0700 | 9,311 |
| Oct 14, 2026 | 0.0725 | 0.0784 | 0.0657 | 0.0698 | 158,608 |
| Oct 13, 2026 | 0.0700 | 0.0787 | 0.0650 | 0.0787 | 204,874 |
| Oct 12, 2026 | 0.0743 | 0.0780 | 0.0633 | 0.0699 | 210,812 |
Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
Insider Trades
No insider transactions for this companyForeign private issuers and non-reporting entities don't file Form 4/5.
Shareholders
--
Institutional
(33)
--
Insiderⓘ
(0)
--
5%+ Owners
(0)
--
Unattributed (incl. retail)ⓘ
Top Shareholders
| Name | Shares | % | Source |
|---|---|---|---|
FourWorld Capital Management LLC TVGNW | 1.4M | -- | 13F |
SUSQUEHANNA INTERNATIONAL GROUP, LLP TVGNW | 1.0M | -- | 13F |
Calamos Advisors LLC TVGNW | 1.0M | -- | 13F |
Parallax Volatility Advisers, L.P. TVGNW | 790.9K | -- | 13F |
Greenland Capital Management LP TVGNW | 703.0K | -- | 13F |
Polar Asset Management Partners Inc. TVGNW | 700.0K | -- | 13F |
MMCAP International Inc. SPC TVGNW | 650.0K | -- | 13F |
LINDEN ADVISORS LP TVGNW | 650.0K | -- | 13F |
Clear Street Group Inc. TVGNW | 282.8K | -- | 13F |
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP TVGNW | 250.0K | -- | 13F |
Sources: 13F
Insiders & Institutional Holders
Top institutional holders
About
Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology.
Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID.
The company is based in Warren, New Jersey.
Key Metrics
Market Cap$5.75M
Enterprise Value--
P/E Ratio-1.03
Est. Net Cash/Share--
Institutional Ownership--
based on 67.88M shares outstanding
Sector--
Industry--
ExchangeNASDAQ
Country
US
IPO DateJan 5, 2022
Shares Outstanding67.88M
Authorized Shares
Float43.58M
52-Week Range
$0.0253$0.1175
$0.0847(64th percentile)
Volume
Average Daily Volume504.13K
758.66K today vs 504.13K avg(+50%)
30d Avg
504.13K
60d Avg
477.14K
90d Avg
394.65K
Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...